Dual antiplatelet therapy monitoring for neurointerventional procedures using a point-of-care platelet function test: a single-center experience.
about
Assessment of platelet inhibition by point-of-care testing in neuroendovascular proceduresFlow-diversion panacea or poison?Potential Usefulness of Clopidogrel Pharmacogenetics in Cerebral Endovascular Procedures and Carotid Artery Stenting.Use of the pipeline embolization device to treat recently ruptured dissecting cerebral aneurysmsAnti-platelet drug resistance in the prediction of thromboembolic complications after neurointerventionSignificance of clopidogrel resistance related to the stent-assisted angioplasty in patients with atherosclerotic cerebrovascular disease.Antiplatelet resistance and thromboembolic complications in neurointerventional procedures.Change of Platelet Reactivity to Antiplatelet Therapy after Stenting Procedure for Cerebral Artery Stenosis: VerifyNow Antiplatelet Assay before and after StentingNeurointerventional Stenting and Antiplatelet Function Testing: To Do or Not to Do?Microembolism after Endovascular Treatment of Unruptured Cerebral Aneurysms: Reduction of its Incidence by Microcatheter Lumen AspirationThe influence of anti-platelet resistance on the development of cerebral ischemic lesion after carotid artery stentingAnticoagulation in neurointerventions: basic pharmacology and pathophysiology, current status, practical advice.Pipeline embolization device for intracranial aneurysm: a systematic review.Stent-assisted coiling versus coiling in treatment of intracranial aneurysm: a systematic review and meta-analysis.Flow diversion for complex middle cerebral artery aneurysms.Platelet function inhibitors and platelet function testing in neurointerventional procedures.Thromboembolic events associated with single balloon-, double balloon-, and stent-assisted coil embolization of asymptomatic unruptured cerebral aneurysms: evaluation with diffusion-weighted MR imaging.Genetic determinations of variable responsiveness to clopidogrel and implications for neurointerventional procedures.The impact of stent design on the structural mechanics of the crossing Y-stent: an in vitro study.Is clopidogrel premedication useful to reduce thromboembolic events during coil embolization for unruptured intracranial aneurysms?Preinterventional clopidogrel response variability for coil embolization of intracranial aneurysms: clinical implications.Clopidogrel hyper-response and bleeding risk in neurointerventional procedures.Incidence of microemboli and correlation with platelet inhibition in aneurysmal flow diversion.Thromboembolic complications in patients with clopidogrel resistance after coil embolization for unruptured intracranial aneurysms.Clopidogrel resistance is associated with thromboembolic complications in patients undergoing neurovascular stenting.Point of care platelet function testing in routine neurointerventional care is unjustified.Clinical and angiographic outcomes in patients with intracranial aneurysms treated with the pipeline embolization device: intra-procedural technical difficulties, major morbidity, and neurological mortality decrease significantly with increased operAccumetrics-based clopidogrel dosing in endovascular neurosurgery.Intravenous administration of tirofiban versus loading dose of oral clopidogrel for preventing thromboembolism in stent-assisted coiling of intracranial aneurysms.Last-recorded P2Y12 reaction units value is strongly associated with thromboembolic and hemorrhagic complications occurring up to 6 months after treatment in patients with cerebral aneurysms treated with the pipeline embolization device.Clopidogrel Resistance in Neurovascular Stenting: Correlations between Light Transmission Aggregometry, VerifyNow, and the Multiplate.Carotid artery stenting outcomes: do they correlate with antiplatelet response assays?P2Y12 Reaction Units: Effect on Hemorrhagic and Thromboembolic Complications in Patients With Cerebral Aneurysms Treated With the Pipeline Embolization Device.Complications of endovascular treatment for intracranial aneurysms: Management and prevention.Comparison of Stent-Assisted Coiling vs Coiling Alone in 563 Intracranial Aneurysms: Safety and Efficacy at a High-Volume Center.Incidence and clinical implications of carotid branch occlusion following treatment of internal carotid artery aneurysms with the pipeline embolization device.Tailoring platelet inhibition according to multiple electrode aggregometry decreases the rate of thrombotic complications after intracranial flow-diverting stent implantation.Variability in initial response to standard clopidogrel therapy, delayed conversion to clopidogrel hyper-response, and associated thromboembolic and hemorrhagic complications in patients undergoing endovascular treatment of unruptured cerebral aneur
P2860
Q26823633-1CFC9B11-6B54-4A7D-B423-048C7957CF7DQ26828999-0B34E4EC-EDD4-472E-83AE-A82B7A08A00AQ33818356-BD3FAFFD-0EFB-4F53-B753-9C36C0A342FFQ34296893-B406606D-673E-4FB3-9758-C480F584AA3BQ34316378-4D4B2B34-9F5E-4AA1-8B2A-BCF649EA138BQ35176063-CD8F17C2-31AA-4F79-B366-F06A65FF6783Q35750126-C9B609A6-5123-4439-AF98-D36188225D77Q35823453-C8FAECD9-3290-4651-AE20-BBB64E8F9450Q35905832-3D834524-59BC-4D2C-B566-330E79A13345Q36064305-9A669332-9801-4306-BA4B-E7FC9CF1D708Q36620421-41357A20-238A-4422-99C4-A7075C88C4F3Q37981910-52537FED-9296-4656-98D2-1400B6682852Q38057641-6C4C31CF-D3D1-4510-8D0C-1778F2B73844Q38181098-1ECA4646-2AB9-4917-B336-21C946F4CE85Q38188804-5445B26F-04DF-4ADE-9454-5A1B7EF99D14Q38233284-BE232FC7-6FE0-41C1-B673-58FB6D6B3DC3Q38245827-8429ABC3-84DF-42BD-A36E-ECB29F9FA26CQ38246009-F8340D58-FDB9-41B3-BF7C-2E6F6D4956E5Q40195906-164217E4-B7FB-42C2-9A54-3F02F23AF4D5Q42876416-403CE0C7-7348-463B-8BD7-90BADB6F6196Q43132755-BF7F6465-FDE0-4F39-A87B-B5FFCADAEF23Q43652213-B20B0BC2-8536-4A1D-AFD9-6562D3CD5E95Q43832091-CB41CD5C-D5AE-4228-A319-EEAE8553D506Q43935346-8BF36A64-1388-4488-8630-A11F8248939CQ44299095-0CE62629-0905-4B98-905A-0BE0B6257D58Q45912513-C2C2E5EF-1065-4D17-B399-43EB1B89E77CQ47593505-8D78F29E-D6E0-4CB1-83E7-5AB5D0316AFDQ48013353-00842800-D0DC-4D11-8D91-D1EEAEBE1229Q48724831-8F98FC81-AD64-4C52-B193-ED16B6D45741Q50857320-24268D36-B00C-4E46-906C-6B5BCB28A8A4Q50867606-95E22D2A-45E3-435C-A5FC-AF9E22A2DC0BQ50883518-1877ADAC-096D-40C7-B9D7-52571CECE10BQ51644306-151DBBB9-C392-458C-9A52-835207A9DE3CQ52375292-2690166F-EA97-4E1B-8D65-FEA255C78B62Q53268022-04C10B05-AE9D-4E2B-A8A7-95E395977FC1Q53351187-6F0259CF-C980-4165-9041-046B708991C7Q53577445-B694F425-EFD3-43AF-8751-2657DD4E8D8FQ54419291-2AE608EE-B488-47A5-9719-4EA2AAAAAFE9
P2860
Dual antiplatelet therapy monitoring for neurointerventional procedures using a point-of-care platelet function test: a single-center experience.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Dual antiplatelet therapy moni ...... t: a single-center experience.
@en
Dual antiplatelet therapy moni ...... t: a single-center experience.
@nl
type
label
Dual antiplatelet therapy moni ...... t: a single-center experience.
@en
Dual antiplatelet therapy moni ...... t: a single-center experience.
@nl
prefLabel
Dual antiplatelet therapy moni ...... t: a single-center experience.
@en
Dual antiplatelet therapy moni ...... t: a single-center experience.
@nl
P2093
P2860
P356
P1476
Dual antiplatelet therapy moni ...... t: a single-center experience.
@en
P2093
P2860
P304
P356
10.3174/AJNR.A1070
P577
2008-05-15T00:00:00Z